Prenatal Care Practice Questions

Q: What is the most accurate tool for gestational age assignment?

First trimester Crown-Rump length. **Explanation:** The determination of accurate gestational age (GA) is the most critical step in prenatal care, as it dictates the timing of screenings, interventions, and management of labor. **Why Option C is Correct:** The **Crown-Rump Length (CRL)** measured via ultrasound in the **first trimester (specifically between 7 and 14 weeks)** is the most accurate method for dating a pregnancy. During this period, biological variation in fetal growth is minimal, and the embryo grows at a highly predictable linear rate. A well-performed CRL measurement has a margin of error of only **±3 to 5 days**. **Why Other Options are Incorrect:** * **A. Menstrual History (LMP):** While traditionally used (Naegele’s rule), it is often unreliable due to irregular cycles, variable ovulation timing, or poor maternal recall. It has a margin of error of ±2 weeks. * **B. Clinical Assessment:** Methods like symphysis-fundal height (SFH) or bimanual examination are subjective and influenced by maternal BMI, multiple gestations, fibroids, and amniotic fluid volume. * **D. Femur Length:** This is a second-trimester parameter. As pregnancy progresses into the second and third trimesters, biological variation increases, making biometry (BPD, HC, AC, FL) less accurate for dating (error margin increases to ±7–21 days). **High-Yield Clinical Pearls for NEET-PG:** * **Golden Rule:** If there is a discrepancy between LMP and first-trimester USG dating of >5 days (up to 8+6 weeks) or >7 days (9 to 13+6 weeks), the **USG date** should be used to re-date the pregnancy. * **CRL Limit:** CRL is used until **13 weeks 6 days**. Beyond 14 weeks, Head Circumference (HC) becomes the most reliable parameter. * **Best Time for CRL:** 11 to 13+6 weeks (also the window for Nuchal Translucency screening).

Q: What is the most reliable fetal parameter for estimating gestational age in the first trimester?

Crown-rump length (CRL). **Explanation:** The **Crown-Rump Length (CRL)** is the most accurate parameter for dating a pregnancy, with a margin of error of only **±3 to 5 days**. In the first trimester, fetal growth is rapid and biological variation is minimal because growth is not yet significantly influenced by external factors (like placental insufficiency) or genetic growth potential. CRL is measured from the top of the head (crown) to the outer margin of the buttocks (rump) and is most reliable between **7 and 13 weeks (+6 days)** of gestation. **Why other options are incorrect:** * **Gestational Sac Diameter (B):** This is the earliest sign of pregnancy on ultrasound, but it is less accurate than CRL due to significant variability in sac shape and size. * **Biparietal Diameter (BPD) (D) & Femur Length (A):** These are the primary parameters used in the **second trimester**. As the pregnancy progresses, biological variation increases, making these measurements less reliable for dating than a first-trimester CRL. BPD has an error margin of ±7–10 days in the second trimester, which increases to ±3 weeks in the third trimester. **High-Yield Clinical Pearls for NEET-PG:** * **Rule of Thumb:** If there is a discrepancy between the Last Menstrual Period (LMP) and the CRL measurement of >5 days in the first trimester, the EDD should be revised based on the ultrasound. * **Upper Limit:** Once the CRL exceeds **84 mm**, BPD becomes the preferred parameter for dating. * **Earliest detection:** A gestational sac is typically seen at 4.5–5 weeks, a yolk sac at 5 weeks, and a fetal pole with cardiac activity at 6 weeks via Transvaginal Sonography (TVS).

Q: A 6-week pregnant lady is diagnosed with sputum positive TB. What is the best management approach?

Start Category I ATT in the first trimester.. **Explanation:** The management of Tuberculosis (TB) in pregnancy is a high-yield topic for NEET-PG. The fundamental principle is that **pregnancy is not a contraindication** to starting Anti-Tubercular Treatment (ATT). **Why Option B is Correct:** According to the National TB Elimination Program (NTEP) and WHO guidelines, a pregnant woman diagnosed with TB should be started on **Category I ATT immediately**, regardless of the trimester. Untreated TB poses a significantly higher risk to both the mother (maternal morbidity) and the fetus (preterm birth, low birth weight, and congenital TB) than the drugs themselves. The standard 6-month regimen (2HRZE + 4HRE) is considered safe in pregnancy. **Why Other Options are Incorrect:** * **Option A:** Delaying treatment until the second trimester allows the disease to progress, increasing the risk of hematogenous spread to the placenta and fetus. * **Option C:** Category II (which included Streptomycin) is no longer the standard of care for new cases. Furthermore, Streptomycin is **contraindicated** in pregnancy as it is ototoxic to the fetus (causes 8th cranial nerve damage). * **Option D:** Category III is an obsolete classification. Treatment should never be delayed until the second trimester for an active sputum-positive case. **Clinical Pearls for NEET-PG:** * **Safe Drugs:** Isoniazid, Rifampicin, Ethambutol, and Pyrazinamide are all safe in pregnancy. * **Pyridoxine (Vitamin B6):** Always co-administer (10–25 mg/day) with Isoniazid in pregnant women to prevent peripheral neuropathy. * **Contraindicated:** Streptomycin (Ototoxicity) and Ethionamide (Teratogenic). * **Breastfeeding:** ATT is not contraindicated during breastfeeding; however, the infant should receive Isoniazid prophylaxis and the BCG vaccine.

Q: A 42-year-old patient, who is 5 weeks pregnant with her fifth baby, is concerned about the risk of Down syndrome due to her advanced maternal age. She has decided to undergo a second-trimester amniocentesis to determine the fetal karyotype. Which of the following is NOT a possible complication of amniocentesis?

Limb reduction defects. **Explanation:** The correct answer is **D. Limb reduction defects**. **1. Why Limb Reduction Defects is the correct answer:** Limb reduction defects are a specific complication associated with **Chorionic Villus Sampling (CVS)**, particularly when performed before 9–10 weeks of gestation. Amniocentesis is typically performed in the second trimester (15–20 weeks), a period after which fetal limb development is complete. Therefore, it does not cause structural limb abnormalities. **2. Analysis of Incorrect Options:** * **A. Amniotic fluid leakage:** This occurs in approximately 1–2% of cases post-procedure. Most cases are managed conservatively with bed rest, and the membranes often seal spontaneously. * **B. Chorioamnionitis:** As an invasive procedure involving a needle entering the sterile amniotic cavity, there is a small but documented risk of introducing infection (less than 1 in 1,000 cases). * **C. Fetal loss rate of less than 0.5%:** Modern ultrasound-guided amniocentesis is very safe. The procedure-related pregnancy loss rate is currently estimated to be between **0.1% and 0.3%** (1 in 300 to 1 in 1,000), which is well below the 0.5% threshold. **3. NEET-PG High-Yield Pearls:** * **Timing:** Mid-trimester amniocentesis is ideally performed at **15–20 weeks**. "Early amniocentesis" (11–13 weeks) is avoided due to higher rates of talipes equinovarus and pregnancy loss. * **CVS vs. Amniocentesis:** CVS can be done earlier (10–13 weeks) but carries a risk of **limb reduction defects** and **confined placental mosaicism**. * **Rh Isoimmunization:** In Rh-negative unsensitized mothers, **Anti-D immunoglobulin** must be administered after amniocentesis to prevent sensitization. * **Gold Standard:** Amniocentesis remains the gold standard for diagnosing fetal chromosomal abnormalities and is the preferred method for detecting neural tube defects (via alpha-fetoprotein levels).

Q: The triple test for Down syndrome screening includes all of the following EXCEPT:

Maternal Inhibin A. The **Triple Test** is a second-trimester screening tool performed between **15 and 20 weeks** of gestation (ideally 16–18 weeks) to assess the risk of chromosomal abnormalities, specifically Trisomy 21 (Down syndrome). ### Why Option D is Correct **Maternal Inhibin A** is not a component of the Triple Test. It is the fourth marker added to the Triple Test to create the **Quadruple (Quad) Test**. Inhibin A increases the sensitivity and detection rate for Down syndrome compared to the triple screen alone. ### Why the Other Options are Incorrect Options A, B, and C are the three standard biochemical markers that constitute the Triple Test: * **Maternal Alpha-fetoprotein (MSAFP):** Produced by the fetal liver; levels are **decreased** in Down syndrome. * **Maternal hCG:** Produced by the placenta; levels are **increased** in Down syndrome. * **Unconjugated Estriol (uE3):** Produced by the syncytiotrophoblast using fetal precursors; levels are **decreased** in Down syndrome. ### Clinical Pearls for NEET-PG * **Down Syndrome Pattern:** Remember the mnemonic **"HI"** is **High**—**H**CG and **I**nhibin A are elevated, while AFP and Estriol are low. * **Edwards Syndrome (Trisomy 18):** All markers (AFP, hCG, and uE3) are typically **decreased**. * **Neural Tube Defects (NTD):** Characterized by an **isolated elevation** of MSAFP. * **Combined Test (First Trimester):** Includes Nuchal Translucency (NT) scan, PAPP-A (decreased), and β-hCG (increased). * **Best Screening Tool:** Non-Invasive Prenatal Testing (NIPT/cfDNA) is currently the most sensitive screening method for Down syndrome (>99%).

Q: All of the following can be used for establishing antenatal diagnosis except:

Decidua. **Explanation:** The goal of prenatal diagnosis is to obtain genetic or biological material belonging to the **fetus** to identify congenital or genetic abnormalities. **Why Decidua is the Correct Answer (The "Except"):** The **decidua** is the modified mucosal lining of the uterus (endometrium) during pregnancy. Crucially, it is of **maternal origin**, not fetal. Therefore, analyzing decidual tissue would provide the mother’s genetic profile rather than the fetus's, making it useless for establishing an antenatal diagnosis of fetal conditions. **Analysis of Other Options:** * **Fetal Blood:** Obtained via **Cordocentesis** (Percutaneous Umbilical Blood Sampling). It is used for rapid karyotyping, detecting fetal infections, or assessing fetal anemia (e.g., Rh isoimmunization). * **Maternal Blood:** Used in **Non-Invasive Prenatal Testing (NIPT)** to analyze Cell-Free Fetal DNA (cffDNA) that leaks into the mother's circulation. It is also used for maternal serum screening (Triple/Quadruple markers) to assess risks for Down syndrome and neural tube defects. * **Amniotic Fluid:** Obtained via **Amniocentesis** (usually at 15–20 weeks). It contains desquamated fetal cells (amniocytes) used for chromosomal analysis, biochemical tests (AFP), and DNA studies. **NEET-PG High-Yield Pearls:** * **Chorionic Villus Sampling (CVS):** Performed at 10–13 weeks; provides the earliest definitive genetic diagnosis. * **NIPT/cffDNA:** Can be performed as early as 10 weeks; it is a screening test, not a diagnostic one. * **Amniocentesis:** The gold standard for definitive prenatal diagnosis; carries a lower risk of miscarriage (0.5%) compared to CVS (1%). * **Confined Placental Mosaicism:** A potential pitfall in CVS where the placenta and fetus have different genetic makeups.

Q: Which of the following is considered a definitive sign of pregnancy?

Fetal heart sound. **Explanation:** In Obstetrics, signs of pregnancy are categorized into three groups: **Presumptive, Probable, and Positive (Definitive).** **Why the correct answer is right:** **Fetal heart sound** is a **Positive (Definitive) sign** of pregnancy. These signs are objective findings that can only be attributed to the presence of a fetus. Fetal heart sounds can be detected via Doppler ultrasound as early as 10–12 weeks and by Pinard fetal stethoscope at 18–20 weeks. Other definitive signs include the visualization of the fetus on ultrasound and the palpation of fetal movements by an examiner. **Why the incorrect options are wrong:** * **Uterine souffle (Option A):** This is a soft, blowing sound heard over the uterus due to increased blood flow in the uterine arteries. It is a **Probable sign** because it can also be heard in cases of large uterine fibroids or vascular pelvic tumors. * **Ballottement (Option B):** This involves feeling the rebound of the fetus against the examiner’s finger. It is a **Probable sign** because a similar sensation can be elicited by a pedunculated subserous fibroid or an ovarian cyst with ascites. * **Amenorrhea (Option C):** This is a **Presumptive sign**. While it is often the first sign of pregnancy, it is highly non-specific and can be caused by stress, endocrine disorders (PCOS), or systemic illness. **High-Yield NEET-PG Pearls:** * **Hegar’s Sign:** Softening of the uterine isthmus (Probable sign). * **Chadwick’s Sign:** Bluish discoloration of the cervix/vagina (Probable sign). * **Quickening:** First perception of fetal movement by the mother (Presumptive sign, not definitive). * **hCG in Urine/Blood:** Considered a **Probable sign** because certain tumors (e.g., Choriocarcinoma) can also secrete hCG.

Q: What is the daily requirement of folate during pregnancy?

500 mcg. **Explanation:** The daily requirement of folate increases significantly during pregnancy to support rapid cell division, fetal growth, and the expansion of maternal red cell mass. **1. Why 500 mcg is correct:** According to the **World Health Organization (WHO)** and the **Ministry of Health and Family Welfare (MoHFW, India)** under the Anemia Mukt Bharat guidelines, the recommended daily intake of folic acid for a pregnant woman is **500 mcg (0.5 mg)**. This dosage is sufficient to prevent maternal megaloblastic anemia and significantly reduce the risk of Neural Tube Defects (NTDs) in the fetus. **2. Analysis of incorrect options:** * **200 mcg (Option A):** This is roughly the recommended dietary allowance (RDA) for a non-pregnant adult female. It is insufficient to meet the physiological demands of pregnancy. * **300 mcg (Option B):** This value is often cited as the requirement for lactating mothers, but it falls short of the pregnancy requirement. * **700 mcg (Option D):** This exceeds the standard recommended dose for a routine pregnancy without specific risk factors. **3. High-Yield Clinical Pearls for NEET-PG:** * **Pre-conception:** Ideally, folic acid (400 mcg) should be started **4 weeks before conception** and continued through the first trimester. * **High-Risk Cases:** For women with a **previous history of a child with NTD**, the dose is increased tenfold to **4 mg (4000 mcg)** daily. * **IFA Tablets:** Under the government's Iron Plus Initiative, the prophylactic dose is **100 mg elemental Iron + 500 mcg Folic Acid** daily for 180 days starting from the second trimester (14 weeks). * **Role:** Folic acid is a co-enzyme for DNA synthesis; deficiency leads to megaloblastic anemia and NTDs (e.g., Anencephaly, Spina Bifida).

Q: O'Sullivan & Mahan criteria is used in which of the following conditions?

Gestational diabetes mellitus. **Explanation:** The **O’Sullivan & Mahan criteria** (1964) were the first standardized diagnostic criteria established for **Gestational Diabetes Mellitus (GDM)**. They were originally based on the risk of the mother developing Type 2 Diabetes later in life, using a 100g 3-hour Oral Glucose Tolerance Test (OGTT) with whole blood samples. These criteria were later modified by Carpenter and Coustan (using plasma values), which remain widely used today. **Why Option B is Correct:** GDM is defined as carbohydrate intolerance with onset or first recognition during pregnancy. The O’Sullivan criteria established the threshold for diagnosis: if two or more values (Fasting, 1hr, 2hr, or 3hr) are met or exceeded during a 100g OGTT, GDM is diagnosed. **Why Other Options are Incorrect:** * **A. Gestational Hypertension:** Diagnosed based on blood pressure readings (≥140/90 mmHg) after 20 weeks of gestation. * **C. Rh Incompatibility:** Managed using the Indirect Coombs Test (ICT) for screening and the Kleihauer-Betke test for quantifying fetal-maternal hemorrhage. * **D. Assessing Progress of Labour:** Evaluated using the **Friedman’s Curve** or the **WHO Partograph**. **High-Yield Clinical Pearls for NEET-PG:** * **DIPSI Criteria:** The most commonly used screening/diagnostic method in India. It involves a 75g glucose load regardless of the last meal; a 2-hour plasma glucose **≥140 mg/dL** is diagnostic of GDM. * **IADPSG Criteria:** Recommended by FIGO; uses a 75g OGTT. Diagnosis is made if **any one** value is abnormal (Fasting ≥92, 1hr ≥180, 2hr ≥153 mg/dL). * **Best Initial Screening:** 50g Glucose Challenge Test (GCT).

Q: Nuchal fold thickness is used to screen for which of the following conditions?

Down syndrome. **Explanation:** **Nuchal Fold Thickness (NFT)** is a classic second-trimester ultrasound marker (measured between 18–22 weeks) used to screen for chromosomal abnormalities, most notably **Down syndrome (Trisomy 21)**. An increased NFT (typically defined as **≥ 6 mm**) is one of the most sensitive and specific "soft markers" for Down syndrome in the second trimester, representing subcutaneous edema at the back of the fetal neck. **Analysis of Options:** * **A. Down syndrome (Correct):** Thickened nuchal fold is strongly associated with Trisomy 21. It is distinct from *Nuchal Translucency (NT)*, which is measured in the first trimester (11–13+6 weeks). * **B. Cri-du-chat syndrome:** This is caused by a deletion on chromosome 5p. While it presents with microcephaly and cardiac defects, NFT is not a standard screening tool for this condition. * **C. DiGeorge syndrome:** Caused by a 22q11.2 deletion. It is primarily screened via fetal echocardiography (looking for conotruncal anomalies) rather than nuchal fold thickness. * **D. Turner syndrome:** While Turner syndrome (45, XO) is associated with increased **Nuchal Translucency** and **Cystic Hygroma** in the first trimester, NFT is specifically the hallmark marker for Down syndrome in the second trimester. **High-Yield Clinical Pearls for NEET-PG:** * **Timing is Key:** Nuchal **Translucency** (NT) = 1st Trimester (11–14 weeks); Nuchal **Fold** (NF) = 2nd Trimester (18–22 weeks). * **Cut-off Value:** NF ≥ 6 mm is considered abnormal. * **Other Soft Markers for Down Syndrome:** Hyperechoic bowel, echogenic intracardiac focus (EIF), short femur/humerus, and pyelectasis. * **Most Sensitive Marker:** Among all second-trimester soft markers, thickened nuchal fold has the highest likelihood ratio for Down syndrome.

Question 1

What is the most accurate tool for gestational age assignment?

Accepted Answer

First trimester Crown-Rump length

Answer

Menstrual history

Answer

Clinical assessment

Answer

Femur length

Question 2

What is the most reliable fetal parameter for estimating gestational age in the first trimester?

Accepted Answer

Crown-rump length (CRL)

Answer

Femur length

Answer

Gestational sac diameter

Answer

Biparietal diameter (BPD)

Question 3

A 6-week pregnant lady is diagnosed with sputum positive TB. What is the best management approach?

Accepted Answer

Start Category I ATT in the first trimester.

Answer

Wait until the second trimester to start anti-TB treatment (ATT).

Answer

Start Category II ATT in the first trimester.

Answer

Start Category III ATT in the second trimester.

Question 4

A 42-year-old patient, who is 5 weeks pregnant with her fifth baby, is concerned about the risk of Down syndrome due to her advanced maternal age. She has decided to undergo a second-trimester amniocentesis to determine the fetal karyotype. Which of the following is NOT a possible complication of amniocentesis?

Accepted Answer

Limb reduction defects

Answer

Amniotic fluid leakage

Answer

Chorioamnionitis

Answer

A fetal loss rate of less than 0.5%

Question 5

The triple test for Down syndrome screening includes all of the following EXCEPT:

Accepted Answer

Maternal Inhibin A

Answer

Maternal HCG

Answer

Maternal Estriol

Answer

Maternal Alphafetoprotein

Question 6

All of the following can be used for establishing antenatal diagnosis except:

Accepted Answer

Decidua

Answer

Fetal blood

Answer

Maternal blood

Answer

Amniotic fluid

Question 7

Which of the following is considered a definitive sign of pregnancy?

Accepted Answer

Fetal heart sound

Answer

Uterine souffle

Answer

Ballottement

Answer

Amenorrhea

Question 8

What is the daily requirement of folate during pregnancy?

Accepted Answer

500 mcg

Answer

200 mcg

Answer

300 mcg

Answer

700 mcg

Question 9

O'Sullivan & Mahan criteria is used in which of the following conditions?

Accepted Answer

Gestational diabetes mellitus

Answer

Gestational hypertension

Answer

Rh incompatibility

Answer

Assessing progress of labour

Question 10

Nuchal fold thickness is used to screen for which of the following conditions?

Accepted Answer

Down syndrome

Answer

Cri-du-chat syndrome

Answer

DiGeorge syndrome

Answer

Turner syndrome

Prenatal Care — MCQs

Prenatal Care — MCQs

On this page

Practice by Chapter

Want unlimited practice?